Given that this last phase of pseudotime 1 (i.e. UMAP clusters 3 and 6) is dominated by CD4+ T-cells from severe patients, these results collectively support that FOXP3-mediated negative feedback on T-cell activation is defective in COVID-19 patients. The gene discussed is CD4; the disease is COVID-19.